Immunohistochemistry Assay, Antibody, Melanoma-Associated Antigen A4
SBL is the FDA product code for Immunohistochemistry Assay, Antibody, Melanoma-Associated Antigen A4, a class III device type, regulated under 21 CFR 864.1860. FDA's definition for this code reads: "Melanoma-associated antigen A4 (MAGE-A4) antibody is a qualitative immunohistochemical antibody, intended for use in the detection of MAGE-A4 protein expression in human clinical tissue specimens. The MAGE A4 antibody is indicated as an aid in identifying patients eligible for treatment with specific FDA approved...". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- SBL
- Device name
- Immunohistochemistry Assay, Antibody, Melanoma-Associated Antigen A4
- FDA definition
- Melanoma-associated antigen A4 (MAGE-A4) antibody is a qualitative immunohistochemical antibody, intended for use in the detection of MAGE-A4 protein expression in human clinical tissue specimens. The MAGE A4 antibody is indicated as an aid in identifying patients eligible for treatment with specific FDA approved therapeutic drugs.
- Regulation
- 21 CFR 864.1860
- Device class
- Class III
- Review panel
- Hematology
- Submission type
- PMA
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
